Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 14, 2022; 28(38): 5626-5635
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5626
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5626
Table 2 Univariate Cox Proportional Hazards Modeling for overall survival
Clinicopathological features | HR (95%CI) | P value |
Sex | ||
Male | Reference | |
Female | 0.278 (0.066-1.172) | P = 0.081 |
Smoking history | ||
Yes | Reference | |
No | 0.605 (0.276-1.323) | P = 0.208 |
Family history of gastric cancer | ||
Yes | Reference | |
No | 0.550 (0.075-4.057) | P = 0.558 |
BMI | ||
18.5-23.9 | Reference | |
> 23.9 or < 18.5 | 2.509 (1.060-5.937) | P = 0.036 |
Postoperative hospital stay | ||
≤ 14 d | Reference | |
> 14 d | 0.990 (0.298-3.292) | P = 0.987 |
Tumor site | ||
Cardia cancer | Reference | |
Non-cardia gastric cancer | 0.411 (0.192-0.878) | P = 0.022 |
The degree of differentiation | ||
Poorly differentiated | Reference | |
Moderately differentiated | 1.330 (0.574-3.082) | P = 0.507 |
Highly differentiated | 0.857 (0.182-4.043) | P = 0.846 |
Vascular invasion | ||
Yes | Reference | |
No | 0.097 (0.044-0.212) | P < 0.001 |
- Citation: Xu Q, Kang WZ, Xiong JP, Shao XX, Li WK, Hu HT, Tian YT. A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy. World J Gastroenterol 2022; 28(38): 5626-5635
- URL: https://www.wjgnet.com/1007-9327/full/v28/i38/5626.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i38.5626